Thoracic Aortic Aneurysm
Definition
A thoracic aortic aneurysm is a permanent, focal enlargement of the thoracic aorta. The US convention in force since 2022 calls the thoracic aorta dilated at ≥4.0 cm and aneurysmal at ≥4.5 cm — deliberately lower than the conventional "1.5 times expected diameter", because dissection risk rises sharply between 4.0 and 4.5 cm and the conventional definition would set the label above the size at which surgery is already offered. (sources/AD-AHA-2022, rating: very high)
The ESC 2024 guideline prefers not to use the word at all: it recommends reporting "significant aortic dilatation" with the diameter or indexed diameter stated, on the grounds that intervention commonly precedes any aneurysmal threshold. (sources/AD-PAD-ESC-2024, rating: very high)
Key Concepts
Measurement — the part that changes decisions
- Measure perpendicular to the axis of blood flow, at reproducible landmarks. Axial images overestimate a tortuous aorta; double-oblique reconstruction is required on CT and MRI.
- Modality fixes the convention: inner-edge to inner-edge on ECG-gated CT/MR, leading-edge to leading-edge on echocardiography. Mixing conventions manufactures apparent growth.
- The root is reported as the maximum sinus-to-sinus diameter, with both long- and short-axis views where it is asymmetric.
- Index to body size when the patient is unusually short or tall, by aortic size index (diameter/BSA), aortic height index (diameter/height), or cross-sectional area/height. A ratio ≥10 cm²/m is an intervention trigger in both the sporadic and bicuspid settings (2a).
- A ≥3 mm/year rise on echocardiography should be confirmed by CT or MRI before it is acted on.
Causes and what they change
| Group | Examples | What it alters |
|---|---|---|
| Degenerative/sporadic | Hypertension, age, smoking | Slowest growth; standard thresholds |
| Heritable (HTAD) | Marfan, Loeys-Dietz, vascular Ehlers-Danlos, ACTA2, PRKG1 | Earlier surgery, family screening, genetic testing — see concepts/Heritable-Thoracic-Aortic-Disease |
| Bicuspid aortic valve | Ascending or root phenotype | Different thresholds by phenotype — see entities/Bicuspid-Aortic-Valve |
| Inflammatory | Takayasu, giant cell arteritis | Steroids first; operate in remission |
| Infectious | Mycotic aneurysm | Open repair preferred; ≥6 weeks of intravenous antibiotics |
| Congenital | Coarctation, aberrant subclavian, Kommerell's diverticulum | Associated lesions must be sought |
Growth rate
- Marfan aortic root 0.26 cm/year (0.46 cm/year above 6.0 cm); bicuspid root phenotype 0.06 cm/year and ascending phenotype 0.03 cm/year; sporadic tricuspid ascending aorta as little as 0.01 cm/year; arch 0.25 cm/year; descending and thoracoabdominal 0.19 cm/year. (sources/AD-AHA-2022)
- Growth rate is itself an intervention trigger: ≥0.5 cm in one year, or ≥0.3 cm/year over two consecutive years in sporadic disease; ≥0.3 cm in one year in HTAD or bicuspid valve.
- Women grow faster than men (0.96 vs 0.45 mm/year in the ESC data) despite smaller baseline diameters — one reason a single diameter threshold undertreats women.
Surveillance
- At diagnosis: transthoracic echocardiography for valve anatomy and function plus root and ascending diameters; CT or MRI for the whole thoracic aorta.
- Then 6–12 months to establish the growth rate, and if stable every 6–24 months depending on diameter.
- Echocardiography is not adequate for the distal ascending aorta, arch or descending aorta (III/C). Those segments require CT or MRI — an explicitly negative recommendation, and one of the few in the guideline. (sources/AD-PAD-ESC-2024)
- After TEVAR: CT at 1 month and 12 months, then annually if stable.
- After open repair without residual disease: CT or MRI within a year, then every 5 years. With residual aortopathy, annually.
- Aortic disease is a whole-aorta disease: assessment at baseline covers the entire aorta, and 20–30% of AAA patients also have a thoracic aneurysm.
Repair thresholds
| Segment / context | Threshold | Class |
|---|---|---|
| Ascending, symptomatic | Any size | I |
| Ascending, sporadic, asymptomatic | ≥55 mm | I |
| Ascending, sporadic, experienced aortic team | ≥50 mm | IIa |
| Ascending tubular aorta, low predicted risk | >52 mm | IIa |
| Ascending at tricuspid valve surgery | ≥45 mm (experienced team) / ≥50 mm | IIa |
| Arch, asymptomatic, low risk | ≥55 mm | IIa |
| Descending thoracic | ≥55 mm | I |
| Thoracoabdominal, degenerative | ≥60 mm (≥55 mm in expert hands) | I / IIa |
| Growth | ≥5 mm in 6 months or ≥10 mm/year (ESC, IIb) | IIb |
| Saccular morphology | Consider earlier — higher risk at the same size | — |
- The two guidelines now converge on numerically similar ascending thresholds via different routes. ACC/AHA lowered 5.5 cm to 5.0 cm for experienced teams; ESC sets 55 mm as Class I and 52 mm as IIa in low-risk patients. Neither is a single number, and neither document will answer "when do I operate?" without knowing the patient and the surgeon.
- Increasing the threshold for high perioperative risk is legitimate and explicitly permitted — the threshold is a population average, not a property of the aorta alone.
Repair: open versus endovascular
- Descending thoracic aorta, no HTAD, suitable anatomy: TEVAR over open repair (I/B). Open repair is for unsuitable anatomy in patients with acceptable comorbidity and ≥10 years of life expectancy.
- Arch: open repair for low-risk asymptomatic patients at ≥55 mm; hybrid or endovascular approaches for high surgical risk (IIb). Hemiarch at the time of ascending repair if dilatation extends into the proximal arch (>50 mm).
- Thoracoabdominal: open repair remains standard for rupture (I); fenestrated and branched endografts are IIa in expert centres with suitable anatomy.
- Marfan, Loeys-Dietz and vascular Ehlers-Danlos: open repair over endovascular for intact thoracoabdominal aneurysm (I). Endografts in these patients are a bridge, not a destination.
- Valve-sparing root replacement is Class I in experienced centres when the valve is repairable — the aortic valve is not automatically replaced by root surgery.
Protecting organs during repair
- Cerebrospinal fluid drainage in open thoracoabdominal repair at high risk of spinal cord ischaemia (Class I, Level A) — one of the few Level A recommendations in the entire guideline.
- Cold blood or crystalloid renal perfusion for thoracoabdominal repair involving the renal arteries (Class I, Level A).
- Revascularise the left subclavian artery before TEVAR with planned coverage to reduce spinal cord ischaemia and stroke (I/B).
- Delayed spinal cord dysfunction is treatable: raise mean arterial pressure, drain CSF, and consider left subclavian revascularisation.
When not to offer repair
- AAA and thoracic repair in patients with life expectancy <2 years is not recommended (III/B for AAA). This is the clearest statement in either guideline that the operation serves the patient's future, not the diameter.
Contradictions / Open Questions
- Two definitions of aneurysm are in simultaneous use. ACC/AHA says 4.5 cm; ESC says report "significant dilatation" with the number and effectively declines to define an aneurysmal threshold. A patient at 4.4 cm is aneurysmal in one system and not the other.
- The 5.0 cm ascending threshold is conditional on an unmeasurable variable. It applies "when performed by experienced surgeons in a Multidisciplinary Aortic Team" — so the recommendation cannot be tested, audited or applied outside a centre that already claims to meet it.
- Women may be systematically undertreated. They dissect at smaller diameters and grow faster, yet the thresholds are largely sex-neutral; ACC/AHA indexes to body size only in patients "significantly shorter or taller than average", which is not the same as sex-specific criteria.
- Most type A dissections occur below the surgical threshold. Around 80% of acute aortic syndromes occur below 55 mm, which means diameter-triggered prophylactic surgery prevents a minority of events. (sources/AD-JACC-2021, rating: high) No alternative trigger has been validated.
- The evidence behind the size thresholds is observational and almost entirely Level C. Only the AAA threshold carries Level A.
- Post-repair surveillance intervals for open versus endovascular repair differ by a factor of five (5 years versus annually) without outcome data comparing the two schedules.
Connections
- Related to concepts/Acute-Aortic-Syndrome — the dissection and rupture end-points the thresholds exist to prevent, sharing the same repair strategy
- Related to concepts/Abdominal-Aortic-Aneurysm — tandem disease in 20–30%
- Related to concepts/Heritable-Thoracic-Aortic-Disease — gene-specific thresholds that override the numbers above
- Related to entities/Bicuspid-Aortic-Valve — phenotype-specific thresholds
- Related to entities/Marfan-Syndrome — the best-characterised aortopathy
- Related to entities/Hypertension — the dominant modifiable risk factor
- Related to concepts/Aortic-Regurgitation — aneurysmal root disease causes it, and valve-sparing repair treats both